Adverse health effects of testosterone deficiency (TD) in men
- PMID: 24942084
- DOI: 10.1016/j.steroids.2014.05.010
Adverse health effects of testosterone deficiency (TD) in men
Abstract
Testosterone and its metabolite, 5α-dihydrotestosterone are critical metabolic and vascular hormones, which regulate a host of biochemical pathways including carbohydrate, lipid and protein metabolism and modulate vascular function. Testosterone deficiency (TD) is a well-recognized medical condition with important health implications. TD is associated with a number of co-morbidities including increased body weight, adiposity and increased waist circumference, insulin resistance (IR) and type 2 diabetes mellitus (T2DM), hypertension, inflammation, atherosclerosis and cardiovascular disease, erectile dysfunction (ED) and increased incidence of mortality. In this review, we summarize the data in the literature on the prevalence of TD and its association with the various co-morbidities and suggest that T therapy is necessary to improve health outcomes in men with TD.
Keywords: Cardiovascular disease; Erectile dysfunction; Mortality; Testosterone; Testosterone deficiency; Type 2 diabetes.
Copyright © 2014 Elsevier Ltd. All rights reserved.
Similar articles
-
Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men.Adv Exp Med Biol. 2017;1043:473-526. doi: 10.1007/978-3-319-70178-3_22. Adv Exp Med Biol. 2017. PMID: 29224108 Review.
-
Testosterone therapy in men with testosterone deficiency: are the benefits and cardiovascular risks real or imagined?Am J Physiol Regul Integr Comp Physiol. 2016 Sep 1;311(3):R566-73. doi: 10.1152/ajpregu.00174.2016. Epub 2016 Aug 3. Am J Physiol Regul Integr Comp Physiol. 2016. PMID: 27488887 Review.
-
Metabolic syndrome in men with low testosterone levels: relationship with cardiovascular risk factors and comorbidities and with erectile dysfunction.J Sex Med. 2013 Oct;10(10):2529-38. doi: 10.1111/jsm.12265. Epub 2013 Jul 30. J Sex Med. 2013. PMID: 23898860
-
Outcomes of testosterone therapy in men with testosterone deficiency (TD): part II.Steroids. 2014 Oct;88:117-26. doi: 10.1016/j.steroids.2014.05.004. Epub 2014 May 24. Steroids. 2014. PMID: 24863426 Review.
-
Testosterone deficiency and risk factors in the metabolic syndrome: implications for erectile dysfunction.Urol Clin North Am. 2011 May;38(2):175-83. doi: 10.1016/j.ucl.2011.02.004. Epub 2011 Apr 3. Urol Clin North Am. 2011. PMID: 21621084 Review.
Cited by
-
Architecture of androgen receptor pathways amplifying glucagon-like peptide-1 insulinotropic action in male pancreatic β cells.Cell Rep. 2023 May 30;42(5):112529. doi: 10.1016/j.celrep.2023.112529. Epub 2023 May 17. Cell Rep. 2023. PMID: 37200193 Free PMC article.
-
Androgens, aging, and prostate health.Rev Endocr Metab Disord. 2022 Dec;23(6):1221-1231. doi: 10.1007/s11154-022-09730-z. Epub 2022 Jun 24. Rev Endocr Metab Disord. 2022. PMID: 35748976 Free PMC article. Review.
-
A National Analysis of Temporal Changes in Prescribing of Testosterone Replacement Therapy Considering Methods of Delivery and Government Regulation.World J Mens Health. 2021 Jan;39(1):83-89. doi: 10.5534/wjmh.190166. Epub 2020 Jul 30. World J Mens Health. 2021. PMID: 32777869 Free PMC article.
-
A cross-sectional survey of adrenal steroid hormones among overweight/obese boys according to puberty stage.BMC Pediatr. 2019 Nov 6;19(1):414. doi: 10.1186/s12887-019-1755-5. BMC Pediatr. 2019. PMID: 31690265 Free PMC article.
-
A stage-dependent link between metabolic syndrome components and incident prostate cancer.Nat Rev Urol. 2018 May;15(5):321-333. doi: 10.1038/nrurol.2018.8. Epub 2018 Feb 13. Nat Rev Urol. 2018. PMID: 29434372 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
